Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My bad, found it
30 days? Link please? It says coming soon
Its not news its fluff! Please tell me what is great about this news?
If this is earth shatter tech, why didn't they tell us about having patents?
Why didn't they say there is no competition, size of the market? Why didnt they get this in front of the big tech blogs, like Tech crunch, Engadget ect.
We all want to protect our kids, so tell me when I have get this awesome app? Is it free, do I have to pay for it? Will it support the 3 major OS's?
Nope, Real News would have provided some tangible info such as
release date
ap stored its available in
Paid or ad based
estimated market size
CHED I completely agree. Swantry is a joke just like Drobbits that was PR'd almost 4 months ago and just faded away.
Sorry but once again the news is lacking. When will it be officially released. Is the product 100% function right now? The website shows its on google play but I checked and its not there. They also show an iphone on the webpage but dont say it will be available for itunes?
Not bashing just stating the obvious facts. I own this stock and I am down quite a bid. Brad need to knock off these fluffy PRs and give us something real.
Why not provide a release date? Why not tell us if its free or ad based, if its a pay app how much?
I am sorry but Brad is incompetent!
Think we will see news this week or just another apology?
Minutes away? Your watch may be broken.
Thought we were getting new lol
Koos taking to twitter again
https://twitter.com/KoosRegen
and what is Manhattan?
WorldFlix, Inc. 6 mins · Palm Springs, CA ·
Sorry for delay - News will be Monday or Tuesday next week. Have a great weekend! - IR TEAM
I agree 100%, glad I am just sitting on free shares. So this waiting as frustrating as it may be, isn't costing me anything.
Now my investment in BMSN is another story, that makes me want to cry.
Wish you were right but I don't see it moving until we have partnering news and by partner I mean Big Pharma or large scale funding in non-toxic form. NIH didnt move it, submission for Orphan didit move it.
Where is the proof of dilution? Anyone can type words, give us proof.
You may want to get a parachute...............
Got a link for that alert? LMFAO
Excellent post!
Exactly what is the PR going to be about? Drobbits? Swanrty? A Movie?
its easy to scream PR repeatedly, tell us what your anticipating it to be about?
Oh really and where did that rumor start?
Regen BioPharma Submits Application to FDA for Orphan Drug Designation for its HemaXellerate Product
PR Newswire
SAN DIEGO, January 26, 2016
SAN DIEGO, January 26, 2016 /PRNewswire/ --
Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today submission to the Food and Drug Administration (FDA) of an application requesting Orphan Drug status for the use of HemaXellerate for the treatment of aplastic anemia.
"Because HemaXellerate is a personalized cell therapy product aimed at addressing an unmet medical need, we are hopeful that the FDA will grant it orphan status," said David Koos, Ph.D., Chairman and CEO of Regen BioPharma.
HemaXellerate is comprised of cells extracted from the patient's own fat tissue and processed using a proprietary method so as to induce a biological response in the patient that heals damaged bone marrow and restores ability of the body to generate healthy blood cells. The FDA recently cleared Regen to perform phase I clinical trials using HemaXellerate in aplastic anemia patients.
Having an Orphan Drug designation for HemaXellerate is important as it will allow for:
•Annual grant funding to defray the cost of clinical testing
•Tax credits for the costs of clinical research
•Assistance in clinical research study design
•Seven-year period of exclusive marketing after an orphan drug is approved
•Waiver of Prescription Drug User Fee Act (PDUFA) filing fees
"Should HemaXellerate be fortunate enough to be designated an Orphan Drug, we will take advantage of the rich resources the National Institutes of Health provides in assisting development of such drugs to get HemaXellerate to market as quickly as possible," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma.
About Regen BioPharma, Inc.
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.
Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Contact:
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
+1-619-702-1404 Phone
+1-619-330-2328 Fax
David.koos@regenbiopharma.com
The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com
http://www.regenbiopharma.com
http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com
Twitter: Regen BioPharma News: https://twitter.com/KoosRegen
SOURCE Regen BioPharma Inc.
Hope Brad sticks to his word and only releases a worthwhile PR. This ticker cant handle another fluff PR. If its for Drobbits and its actually functional,I hope he has the sense to get it in front of the tech blogs.
I completely agree, it could be amazing but these guys cant afford to put out a PR or even fully develop the products they have already PR'd or talked about on twitter and FB. That island would cost 100s of millions if not billions to develop into a fully functional working platform. They should try to sell it to Elon Musk, thats right up his ally and he can write the check.
LOL your been posting here for 11 days and your an expert here suddenly? Id love to be wrong but this will hit trips before it does anything.
LMAFO its nothing more then a joke and Brad himself said its nothing more then a side project. its not being focused on at all.
No more PM's but I now how you feel. We got clobbered up here last yr, had a few storms 24+
CT here not too bad so far only 4-6" but windy as hell.
Hate to sound like a basher but TIMBER!!
LMAO hell no, I was busting on Horse again. He is always tring to glorify this turdtastic stock
Personally I think Brad is over his head. The only thing I have seen him do successfully is pay for a bunch of very unsuccessful stock promotions that only dropped the price.
If you look at his career history he does not stay anywhere long, except for the company he started and sold. After that he has just bounced around every few yrs. Lets face it, if he was a rockstar those other companies wouldn't have let him go.
He doent put out PR because there is noting but smoke and mirrors here. Now he hopes his fluffy tweets and FB posts will move this thing.
Time for Brad to remove his head from his a55 and doing something. No more meaningless FB and twitter posts. We need real tangible news.
Horse do you think we have been halted again or it just that this stock is a POS?
Any time, I am still learning about investing any day. I only knew that because I own a small company.
Fiscal yr and not calendar yr.
Little sisters (ENTB) 10-Q is out
Fortunately I have minimal holdings, I will wait/hope for a pop to around .005 and i'm out. Getting that "i need to take a shower" feeling every time he posts.
BruceBill, to put an end to the gagged TA issue.
Why not have them email you the current OS and simply cut and paste the email here? It would certainly quite many here.
Not bashing I think this has great potential but where are the funds for the share buy back coming from if there is no revenues?